Le Lézard
Classified in: Health, Science and technology
Subject: PDT

VisualDx Launches Aysa for Consumers to Check Skin Conditions Using AI


SANTA CLARA, Calif., Sept. 17, 2018 /PRNewswire/ -- Today, VisualDx, the leading diagnostic clinical decision support tool for physicians, unveiled its first app geared at consumers, Aysa, at the Health 2.0 Conference in Santa Clara. Aysa, an artificial intelligence driven symptom checker app, allows consumers to become more educated and make more informed decisions about their personal skin conditions. Aysa is trained through the VisualDx platform which combines clinical search and medical knowledge from experts with a database of more than 120,000 of the best medical images in the world.

In 2017, the average wait time in metro areas to see a dermatologist for a routine skin exam was 32 days. Using machine learning, Aysa is able to provide real-time results for skin photos taken in the privacy of a consumer's home.

Skin rashes, which can range from annoying but benign to a sign of a serious condition, can look different on different skin types, even if they are the same condition. From psoriasis to eczema to herpes, skin conditions come in different shapes, sizes and severity. By simply taking a photo of one's skin condition and answering a few questions, Aysa is able to generate a few possible answers in addition to next steps whether for self-care measures or for a visit with a health care provider.

"Aysa is a terrific tool to help narrow down a list of potential skin diagnoses. I recently had a large red spot on the area around my thumb and was concerned since I didn't know what it could be," said Jennifer, an early beta tester of the app, who lives in Boston. "With the help of Aysa, I was able to take a picture of the spot, answer a few questions and review some of the possibilities. Turns out the spot was something called a lime rash that I had gotten from squeezing limes a few days prior. Aysa correctly identified the rash on my hand and put my mind at ease before visiting a dermatologist. It was intuitive, easy to follow and a lot faster than what I normally do by searching the internet."

VisualDx, the developer of Aysa, is a physician-led company with a deep knowledge base and understanding of dermatology making it uniquely qualified to bring this app to market. The company is introducing Aysa as a way to augment health research, but not replace the role of a clinician. In doing so, Aysa does not diagnose yet it is able to generate potential diseases and next steps for individuals with common skin conditions, thanks to the power of its world-class medical image library and the use of Apple's CoreML, a framework designed to speed up machine learning tasks on the iOS operating system.

Because it is developed for iOS-based devices, Aysa can adjust its results based on a user's medical history, thereby truly customizing the experience further for users. Because Apple enables users to aggregate existing health records from participating providers in the Apple Health app on iPhones, apps like Aysa and others, can interact with existing data with a user's permission.

"Industry data suggests that nearly 80 percent of internet users have searched for a health-related topic online, however 50 percent of the time these searches produce inaccurate information," said Dr. Art Papier, CEO of VisualDx. "Consumers in the U.S. deserve better and Aysa can provide peace of mind by serving as the foundation for a productive visit to the doctor's office. We want people to use their smartphones to get the right answers when they need it most, and for the answers to be drawn from the professional knowledge of physicians."

Aysa, which will cost $9.99 for a one-year subscription, can be downloaded in the Apple App Store. For a limited time, new users can download Aysa free of charge. An Android version of Aysa is currently under development. For more information, visit www.askaysa.com.

VisualDx is an award-winning diagnostic clinical decision support system and a standard electronic resource at medical schools and in hospital and clinic settings. VisualDx combines clinical search with a database of more than 120,000 of the best medical images in the world, plus medical knowledge from experts to help with diagnosis, treatment, self-education, and patient communication. Expanding to provide diagnostic decision support across general medicine, VisualDx brings increased speed and accuracy to the art of diagnosis. Learn more at www.visualdx.com.

SOURCE VisualDx


These press releases may also interest you

at 21:05
The Board of Directors of TransAlta Corporation declared a quarterly dividend of $0.06 per common share payable on July 1, 2024 to shareholders of record at the close of business on June 1, 2024. The Board of Directors also declared the following...

at 21:02
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...

at 21:00
Research from Omdia's newly released Large Area Display Market Tracker 4Q23 has found shipments of large-area displays (all displays above 9inches), including both LCD and OLED, are forecasted to increase by 7.4% year-over-year (YoY) in units and...

at 20:56
Freed-Hardeman University will offer a new computer engineering program in the fall of 2024, providing students with the opportunity to enter a first cohort for a Bachelor of Science in engineering...

at 20:55
Quorum Information Technologies Inc. ("Quorum"), a North American SaaS Software and Services company providing essential enterprise solutions that automotive dealerships and Original Equipment Manufacturers ("OEMs") rely on for their operations,...

at 20:16
Evolution Equity Partners announced the final closing of Evolution Technology Fund III, LP on April 16th, 2024, and total capital commitments of $ 1.1 Billion to back visionary entrepreneurs building next generation...



News published on and distributed by: